
James L. Rogers
Examiner (ID: 18465, Phone: (571)270-5374 , Office: P/1644 )
| Most Active Art Unit | 1644 |
| Art Unit(s) | 1644, 1641 |
| Total Applications | 491 |
| Issued Applications | 295 |
| Pending Applications | 0 |
| Abandoned Applications | 199 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 12927919
[patent_doc_number] => 09828418
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2017-11-28
[patent_title] => Process for enriching IgA
[patent_app_type] => utility
[patent_app_number] => 14/377535
[patent_app_country] => US
[patent_app_date] => 2013-03-08
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 12
[patent_figures_cnt] => 18
[patent_no_of_words] => 8552
[patent_no_of_claims] => 26
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 88
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14377535
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/377535 | Process for enriching IgA | Mar 7, 2013 | Issued |
Array
(
[id] => 9345215
[patent_doc_number] => 08664363
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2014-03-04
[patent_title] => 'Humanized anti-CD22 antibodies and their use in treatment of oncology, transplantation and autoimmune disease'
[patent_app_type] => utility
[patent_app_number] => 13/781009
[patent_app_country] => US
[patent_app_date] => 2013-02-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 53
[patent_figures_cnt] => 63
[patent_no_of_words] => 83402
[patent_no_of_claims] => 9
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 275
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13781009
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/781009 | Humanized anti-CD22 antibodies and their use in treatment of oncology, transplantation and autoimmune disease | Feb 27, 2013 | Issued |
Array
(
[id] => 10225809
[patent_doc_number] => 20150110802
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2015-04-23
[patent_title] => 'ANTIBODY PRODUCTION METHODS'
[patent_app_type] => utility
[patent_app_number] => 14/380128
[patent_app_country] => US
[patent_app_date] => 2013-02-26
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 13
[patent_figures_cnt] => 13
[patent_no_of_words] => 15673
[patent_no_of_claims] => 19
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14380128
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/380128 | ANTIBODY PRODUCTION METHODS | Feb 25, 2013 | Abandoned |
Array
(
[id] => 9003058
[patent_doc_number] => 20130224183
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2013-08-29
[patent_title] => 'FRACTION I-IV-1 PRECIPITATION OF IMMUNOGLOBINS FROM PLASMA'
[patent_app_type] => utility
[patent_app_number] => 13/776448
[patent_app_country] => US
[patent_app_date] => 2013-02-25
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 1
[patent_no_of_words] => 56182
[patent_no_of_claims] => 61
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13776448
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/776448 | Fraction I-IV-1 precipitation of immunoglobins from plasma | Feb 24, 2013 | Issued |
Array
(
[id] => 9806296
[patent_doc_number] => 20150018241
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2015-01-15
[patent_title] => 'FC-RECEPTOR BASED AFFINITY CHROMATOGRAPHY'
[patent_app_type] => utility
[patent_app_number] => 14/378808
[patent_app_country] => US
[patent_app_date] => 2013-02-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 12
[patent_figures_cnt] => 12
[patent_no_of_words] => 26299
[patent_no_of_claims] => 59
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14378808
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/378808 | FC-RECEPTOR BASED AFFINITY CHROMATOGRAPHY | Feb 13, 2013 | Abandoned |
Array
(
[id] => 9107121
[patent_doc_number] => 20130280253
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2013-10-24
[patent_title] => 'IL-1 BINDING PROTEINS'
[patent_app_type] => utility
[patent_app_number] => 13/760729
[patent_app_country] => US
[patent_app_date] => 2013-02-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 32934
[patent_no_of_claims] => 12
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13760729
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/760729 | IL-1 BINDING PROTEINS | Feb 5, 2013 | Abandoned |
Array
(
[id] => 8842232
[patent_doc_number] => 20130137860
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2013-05-30
[patent_title] => 'Purification Of Proteins'
[patent_app_type] => utility
[patent_app_number] => 13/747495
[patent_app_country] => US
[patent_app_date] => 2013-01-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 4
[patent_no_of_words] => 13710
[patent_no_of_claims] => 6
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13747495
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/747495 | Purification of proteins | Jan 22, 2013 | Issued |
Array
(
[id] => 12367353
[patent_doc_number] => 09957319
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2018-05-01
[patent_title] => Method of isolating human antibodies
[patent_app_type] => utility
[patent_app_number] => 14/368749
[patent_app_country] => US
[patent_app_date] => 2013-01-02
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 5
[patent_figures_cnt] => 6
[patent_no_of_words] => 11750
[patent_no_of_claims] => 14
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 190
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14368749
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/368749 | Method of isolating human antibodies | Jan 1, 2013 | Issued |
Array
(
[id] => 14639071
[patent_doc_number] => 10364268
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2019-07-30
[patent_title] => Ion exchange membrane chromatography
[patent_app_type] => utility
[patent_app_number] => 14/365449
[patent_app_country] => US
[patent_app_date] => 2012-12-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 16
[patent_figures_cnt] => 16
[patent_no_of_words] => 19409
[patent_no_of_claims] => 21
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 235
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14365449
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/365449 | Ion exchange membrane chromatography | Dec 17, 2012 | Issued |
Array
(
[id] => 11684977
[patent_doc_number] => 09683012
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2017-06-20
[patent_title] => 'Method of antibody purification'
[patent_app_type] => utility
[patent_app_number] => 14/365027
[patent_app_country] => US
[patent_app_date] => 2012-12-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 9
[patent_figures_cnt] => 12
[patent_no_of_words] => 11138
[patent_no_of_claims] => 18
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 145
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14365027
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/365027 | Method of antibody purification | Dec 13, 2012 | Issued |
Array
(
[id] => 10968394
[patent_doc_number] => 20140371427
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2014-12-18
[patent_title] => 'IgG2 DISULFIDE ISOFORM SEPARATION'
[patent_app_type] => utility
[patent_app_number] => 14/363735
[patent_app_country] => US
[patent_app_date] => 2012-12-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 21
[patent_figures_cnt] => 21
[patent_no_of_words] => 11533
[patent_no_of_claims] => 22
[patent_no_of_ind_claims] => 14
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14363735
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/363735 | IgG2 DISULFIDE ISOFORM SEPARATION | Dec 6, 2012 | Abandoned |
Array
(
[id] => 10851214
[patent_doc_number] => 08877896
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2014-11-04
[patent_title] => 'Compositions, methods and kits for modeling, diagnosing, and treating complement disorders'
[patent_app_type] => utility
[patent_app_number] => 13/692734
[patent_app_country] => US
[patent_app_date] => 2012-12-03
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 25
[patent_figures_cnt] => 57
[patent_no_of_words] => 43678
[patent_no_of_claims] => 7
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 42
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13692734
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/692734 | Compositions, methods and kits for modeling, diagnosing, and treating complement disorders | Dec 2, 2012 | Issued |
Array
(
[id] => 8865598
[patent_doc_number] => 20130149301
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2013-06-13
[patent_title] => 'ANTI-CD137 ANTIBODY AS AN AGENT IN THE TREATMENT OF INFLAMMATORY CONDITIONS'
[patent_app_type] => utility
[patent_app_number] => 13/688278
[patent_app_country] => US
[patent_app_date] => 2012-11-29
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 36
[patent_figures_cnt] => 36
[patent_no_of_words] => 19336
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13688278
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/688278 | ANTI-CD137 ANTIBODY AS AN AGENT IN THE TREATMENT OF INFLAMMATORY CONDITIONS | Nov 28, 2012 | Abandoned |
Array
(
[id] => 10926974
[patent_doc_number] => 20140329995
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2014-11-06
[patent_title] => 'AFFINITY CHROMATOGRAPHY MATRIX'
[patent_app_type] => utility
[patent_app_number] => 14/358821
[patent_app_country] => US
[patent_app_date] => 2012-11-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 1
[patent_no_of_words] => 4824
[patent_no_of_claims] => 22
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14358821
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/358821 | Affinity chromatography matrix | Nov 27, 2012 | Issued |
Array
(
[id] => 10026094
[patent_doc_number] => 09067983
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2015-06-30
[patent_title] => 'Anti-inflammatory antibodies and uses therefor'
[patent_app_type] => utility
[patent_app_number] => 13/668515
[patent_app_country] => US
[patent_app_date] => 2012-11-05
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 8
[patent_figures_cnt] => 8
[patent_no_of_words] => 18444
[patent_no_of_claims] => 10
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 65
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13668515
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/668515 | Anti-inflammatory antibodies and uses therefor | Nov 4, 2012 | Issued |
Array
(
[id] => 9785157
[patent_doc_number] => 20140301977
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2014-10-09
[patent_title] => 'OVERLOAD AND ELUTE CHROMATOGRAPHY'
[patent_app_type] => utility
[patent_app_number] => 14/355818
[patent_app_country] => US
[patent_app_date] => 2012-11-02
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 13
[patent_figures_cnt] => 13
[patent_no_of_words] => 35162
[patent_no_of_claims] => 44
[patent_no_of_ind_claims] => 12
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14355818
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/355818 | OVERLOAD AND ELUTE CHROMATOGRAPHY | Nov 1, 2012 | Abandoned |
Array
(
[id] => 9757577
[patent_doc_number] => 20140288278
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2014-09-25
[patent_title] => 'CHROMATOGRAPHY PROCESS FOR RESOLVING HETEROGENEOUS ANTIBODY AGGREGATES'
[patent_app_type] => utility
[patent_app_number] => 14/355014
[patent_app_country] => US
[patent_app_date] => 2012-10-25
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 12
[patent_figures_cnt] => 12
[patent_no_of_words] => 19605
[patent_no_of_claims] => 12
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14355014
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/355014 | CHROMATOGRAPHY PROCESS FOR RESOLVING HETEROGENEOUS ANTIBODY AGGREGATES | Oct 24, 2012 | Abandoned |
Array
(
[id] => 8683924
[patent_doc_number] => 20130052208
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2013-02-28
[patent_title] => 'Process for Preparing an Immunoglobulin Composition'
[patent_app_type] => utility
[patent_app_number] => 13/655649
[patent_app_country] => US
[patent_app_date] => 2012-10-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 1
[patent_no_of_words] => 9910
[patent_no_of_claims] => 38
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13655649
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/655649 | Process for preparing an immunoglobulin composition | Oct 18, 2012 | Issued |
Array
(
[id] => 13051525
[patent_doc_number] => 10047144
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2018-08-14
[patent_title] => Methods of purifying antibodies
[patent_app_type] => utility
[patent_app_number] => 13/655955
[patent_app_country] => US
[patent_app_date] => 2012-10-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 9
[patent_figures_cnt] => 13
[patent_no_of_words] => 7931
[patent_no_of_claims] => 8
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 152
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13655955
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/655955 | Methods of purifying antibodies | Oct 18, 2012 | Issued |
Array
(
[id] => 9832060
[patent_doc_number] => 08940877
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2015-01-27
[patent_title] => 'Method to produce an immunoglobulin preparation with improved yield'
[patent_app_type] => utility
[patent_app_number] => 13/653332
[patent_app_country] => US
[patent_app_date] => 2012-10-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 10
[patent_figures_cnt] => 11
[patent_no_of_words] => 33259
[patent_no_of_claims] => 27
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 179
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13653332
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/653332 | Method to produce an immunoglobulin preparation with improved yield | Oct 15, 2012 | Issued |